Font Size: A A A

Nevada Cancer Control Summit

Nevada Cancer Control Summit

Thank you for joining us in Las Vegas for this year’s event!
Save the Date: September 13, 2022 in Reno

Hosted by Nevada Cancer Coalition, the Nevada Cancer Control Summit is a statewide conference featuring sessions on targeted topics across the cancer spectrum. The Summit brings together physicians, nurses, advocates, survivors, administrators, and more to share cutting-edge information, update practitioners on the latest topics in cancer care, and strengthen the coalition to further cancer control efforts in Nevada.

The Summit offers continuing education credits for physicians, nurses, cancer registry professionals, and oftentimes credits for other specialty areas. Click the CME/CE tab for updated credit information.


This conference is supported, in part, by exhibits in accordance with the ACCME standards for Commercial Support:


Cure 4 The Kids Foundation

Dignity Health St. Rose Dominican





Caris Life Sciences

Clovis Oncology

Coherus Biosciences

Gilead Sciences, Inc.

Guardant Health

Nevada Oncology Society


Servier Pharmaceuticals

State of Nevada

Summit Tote Sponsor

Cure 4 The Kids Foundation

Activity Sponsors

Exhibitor Bingo Sponsor - Who doesn't like to sponsor games?

Breakfast & Break Sponsor - Comprehensive Cancer Centers of Nevada

Awards Luncheon Sponsor - PhRMA

Silver Level


American Cancer Society



Bristol Myers Squibb

Daiichi Sankyo

Eli Lilly



MorphoSys US

Nevada Cancer Research Foundation

Nevada Partnership to Fight Chronic Disease


Bronze Level

Ambry Genetics


AVEO Oncology


Center for Hope at Huntsman Cancer Institute

Janssen Pharmaceuticals

Karyopharm Therapeutics


Northern Nevada Children's Cancer Foundation

Funding for this conference was made possible (in part) by the Centers for Disease Control and Prevention through a grant by the Nevada Division of Public and Behavioral Health Nevada Central Cancer Registry, number 5NU58DP006306-02. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


7 a.m. - 8:30 a.m.
Registration, Breakfast and Exhibits

8:30 - 9:15 a.m.
The Future of Cancer Care in Nevada: Addressing Workforce Shortages and Capacity Issues

John Packham, PhD, University of Nevada, Reno

  • Discuss the key drivers of current and future health workforce demand in Nevada
  • Assess the current supply of physicians, nurses, and the cancer-care workforce in Nevada
  • Evaluate state and federal policy measures to address health workforce shortages and cancer-care needs in Nevada

9:15 - 10 a.m.
Detecting Early Stage Cancer with a Blood Test

Tina Clarke Dur, PhD, MPH, Head of Epidemiology & Senior Principal Clinical Scientist, GRAIL

  • Discuss the cumulative burden of late-stage cancer diagnosis, especially for unscreened cancers
  • Review the science of blood-based cancer detection signals and the promise of multi-cancer early detection to complement standard-of-care cancer screenings
  • Identify barriers that must be overcome for adoption of multi-cancer detection and further innovation in this space

10 - 10:30 a.m.
Break and Exhibits

10:30 - 11:15 a.m.
Addressing Breast Reconstruction BEFORE and AFTER Mastectomy

Joshua Goldman, MD, University of Nevada Las Vegas

  • Apply the lessons learned from the review of patient morbidity and mortality cases in Nevada
  • Discuss health care disparities affecting breast cancer survivors in Nevada, particularly in the rural areas
  • Describe health policy and legislation protecting breast cancer survivors and their options for breast reconstruction
  • Evaluate opportunities to improve standards of care, including delayed breast reconstruction in breast cancer survivors
  • Discuss advances in breast reconstruction options

11:15 a.m. - 12 p.m.
Genetics in Cancer Risk Assessment and Treatment

Courtney Rowe-Teeter, MS, CGC, Stanford Cancer Center

  • Describe the importance of and advances in cancer genetic risk assessment for cancer prevention and early detection
  • Review the potential implications of germline genetic testing in cancer treatment
  • Discuss the research showing improved access to care through telegenetic counseling
  • Identify resources to help patients across the state access genetic counseling and genetic testing

12 - 1:30 p.m.
Summit Awards Luncheon and Exhibits

1:30 - 2:15 p.m.
Tobacco Control and Health Equity

David Wetter, PhD, Center for Health Outcomes and Population Equity at the University of Utah and Huntsman Cancer Institute

  • Describe the public health impact of tobacco and its role in health inequities
  • Discuss implementation of tobacco cessation implementation strategies in primary care
  • Describe pilot, program design, and results of “quit-line” pull strategy

2:15 - 3 p.m.
Compassion Fatigue

Christina Alsop, APRN, DNP, Renown Health

  • Review the definition of compassion fatigue and the effects it has on healthcare professionals
  • Identify self-care techniques and strategies in order to combat compassion fatigue

3 - 3:15 p.m.
Break and Exhibits

3:15 - 4 p.m.
Innovations in the Treatment of Brain Cancer

Samual Francis, MD, MS, Comprehensive Cancer Centers

  • Understand current standard of care treatment recommendations for brain tumors
  • Discuss recent innovations in treatment of brain tumors
  • Discuss future directions and ongoing clinical studies for brain tumors

4 - 5 p.m.
Sex, Peanut Butter, and Religion and Other Well-Known Causes of Cancer

James Cohen, MD, Renown Health

  • Discuss natural, environmental, and man-made causes of cancer and what steps can be taken to prevent it


The University of Nevada, Reno School of Medicine approves this program for 6 hours of nursing continuing education credit.

2021 Nevada Cancer Control Summit program supports 6 CE hours of which 5.25 meet the Category A requirement

CME Accreditation & Designation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada, Reno School of Medicine and the Nevada Cancer Coalition. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education in physicians.

The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 6 hours AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.